Skip to content
2000
Volume 23, Issue 26
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the last decades, glial cells started to be considered as alternative targets for neuroprotection. Novel treatments for hypoxia-ischemia intend to modulate reactive forms of glial cells, and/or potentiate their recovery response. In this review, we summarize these neuroprotective strategies in hypoxia-ischemia and discuss their mechanisms of action.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612823666170727145422
2017-07-01
2025-04-15
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612823666170727145422
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test